Peripheral Neuropathy Trial, Recruiting (NCT07493226)

Peripheral Neuropathy Trial, Recruiting NCT07493226 Sponsor: Konya Beyhekim Training and Research Hospital Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT07493226 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 75 years old
You have had shoulder pain for at least one month and have been diagnosed with primary frozen shoulder
Your pain level is at least 4 out of 10 on a pain scale
Your shoulder movement is significantly limited (restricted by 30 degrees or more) in at least two directions, such as raising your arm forward, out to the side, or rotating it outward
You do not meet any of the exclusion criteria listed below and are willing to take part voluntarily

Who may not be able to join:

You have had a shoulder injury in the past, or you have another condition causing pain and reduced function in your arm (such as tennis elbow or tendon problems in the hand or wrist)
You have a neurological condition such as a stroke, nerve damage in the shoulder area, Parkinson's disease, or a neck spine injury (with or without nerve-related symptoms)
You have had surgery on your shoulder, a tumour or cancer in or near the shoulder, or a procedure where the shoulder was forcibly moved under anaesthesia
You have shoulder arthritis, a torn rotator cuff, or a condition called thoracic outlet syndrome (confirm with trial site)
You have a whole-body disease affecting the shoulder, severe joint wear and tear, rheumatoid arthritis, or a history of injuries to the cartilage or socket lining of the shoulder
You have had a steroid injection into the affected arm in the last 3 months, or you are currently taking steroid tablets, anti-inflammatory painkillers (NSAIDs), or receiving any other treatment for this condition
You are pregnant or breastfeeding
You have uncontrolled diabetes, heart failure, or another serious uncontrolled health condition such as liver disease, chronic kidney disease, or a significant hormonal disorder
You have difficulty communicating or have a severe psychiatric condition
You are allergic to anti-inflammatory painkillers (NSAIDs) or have any medical reason you cannot take them
You have a bleeding or clotting disorder, a stomach ulcer, or significant stomach inflammation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07493226

Sponsor: Konya Beyhekim Training and Research Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

More information: https://clinicaltrials.gov/study/NCT07493226

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 75 years old
You have had shoulder pain for at least one month and have been diagnosed with primary frozen shoulder
Your pain level is at least 4 out of 10 on a pain scale
Your shoulder movement is significantly limited (restricted by 30 degrees or more) in at least two directions, such as raising your arm forward, out to the side, or rotating it outward
You do not meet any of the exclusion criteria listed below and are willing to take part voluntarily

Who may not be able to join:

You have had a shoulder injury in the past, or you have another condition causing pain and reduced function in your arm (such as tennis elbow or tendon problems in the hand or wrist)
You have a neurological condition such as a stroke, nerve damage in the shoulder area, Parkinson's disease, or a neck spine injury (with or without nerve-related symptoms)
You have had surgery on your shoulder, a tumour or cancer in or near the shoulder, or a procedure where the shoulder was forcibly moved under anaesthesia
You have shoulder arthritis, a torn rotator cuff, or a condition called thoracic outlet syndrome (confirm with trial site)
You have a whole-body disease affecting the shoulder, severe joint wear and tear, rheumatoid arthritis, or a history of injuries to the cartilage or socket lining of the shoulder
You have had a steroid injection into the affected arm in the last 3 months, or you are currently taking steroid tablets, anti-inflammatory painkillers (NSAIDs), or receiving any other treatment for this condition
You are pregnant or breastfeeding
You have uncontrolled diabetes, heart failure, or another serious uncontrolled health condition such as liver disease, chronic kidney disease, or a significant hormonal disorder
You have difficulty communicating or have a severe psychiatric condition
You are allergic to anti-inflammatory painkillers (NSAIDs) or have any medical reason you cannot take them
You have a bleeding or clotting disorder, a stomach ulcer, or significant stomach inflammation

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Konya Beyhekim Training and Research Hospital

Registry

ClinicalTrials.gov

Start date

1 April 2026

Est. completion

28 February 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

VAS pain (0-10) (night and movement); Range of motion (ROM); SPADI :Shoulder Pain and Disability Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov